← Back to all trials
Not Yet Recruiting
NCT05637931
Plexin D1 as a Potential Biomarker inPM/DM
Conditions: Polymyositis, Dermatomyositis
Sex: All
Healthy volunteers: 1
Enrollment: 66
Sponsor: Assiut University
Summary
evaluation of level of serum circulating plexin D1 on extacellular vesicles in adult PM/DM patients and juvenile dermatomysitis.
Eligibility Criteria
Inclusion Criteria:Adult PM/DM patients .Juvenile dermatomyositis patients.Exclusion Criteria:1-Patients with other autoimmune diseases ( rheumatoid arthritis ,systemic lupus erythematosus, polyarteritis nodosa sarcoidosis, scleroderma, spondylarthritis and inflammatory bowel disease) 2-Patients with malignant tumors 3-Patients with active infection 4-Patients with severe heart, lung, and kidney dysfunction
Source: ClinicalTrials.gov (NCT05637931). StuddyBuddy aggregates publicly available trial information.